A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
Clinical trial NCT03988114 · WITHDRAWN
Trial details
- NCT number
- NCT03988114
- Sponsor
- Eli Lilly and Company
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-16
- Primary completion
- 2022-03-23
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.